Argan, Inc.
NYSE:AGXEngineering & Construction
+$29.13 today
- Market cap
- $4.26B
- Beta
- 0.59
- P/E (TTM)
- 62.3
- EPS (TTM)
- $11.55
- Dividend yield
- 0.26%
Volume 0.30M
Average 0.42M
AGX Sales of Investments
Cash received from selling or redeeming investments.
Argan, Inc.NYSE: AGX
Sales of Investments · Q2 FY2027 · quarter ended Jul 2026
Sales of investments growth accelerates
Q2 FY2027 sales of investments of $30M rose 100.0% year over year, ahead of the +36.0% change in trailing-twelve-month sales of investments. Sequentially, it rose 140.0% from the prior quarter. Over 3 fiscal years it compounded at -7.6% a year.
Context
- Sales of investments amounted to 15.9% of revenue in FY2026, down 1.2 pp from a year earlier.
- Sales of investments increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +100.0% holds above the trailing-twelve-month pace of +36.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2026
- 150M USD
- Year-over-year change
- +0.5%
- 4-year CAGR
- +13.6%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 150M | +0.5% |
| FY2025 | 2025-01-31 | 149.23M | -6.6% |
| FY2024 | 2024-01-31 | 159.75M | -15.9% |
| FY2023 | 2023-01-31 | 190M | +111.1% |
| FY2022 | 2022-01-31 | 90M | — |
Sales of Investments vs competitors
How AGX compares with its peers on the latest reported figures
- AGX's LTM Jul 2026 sales of investments of $157.5M is the 2nd largest of the 10 companies compared; the peer median is $1.81M.
- Its year-over-year change of +36.0% is the 4th highest of 6, against a peer median of +51.5%.
- Sales of investments amounts to 13.3% of revenue for AGX, versus a peer median of 0.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $174.13M | +469.0% | +40.7% | 3.5% | |
| LTM Jul 2026 | $157.5M | +36.0% | -7.6% | 13.3% | |
| LTM Jun 2026 | $157.15M | +14.7% | +58.2% | 3.2% | |
| LTM Jun 2026 | $43.01M | +51.5% | +60.8% | 0.7% | |
| LTM Jun 2026 | $8M | — | — | 0.4% | |
| LTM Jun 2026 | $1.81M | +201.2% | — | 0.1% | |
CSWCSW Industrials, Inc. | LTM Jun 2026 | $229K | — | — | 0.0% |
ECGEverus Construction Group, Inc. | LTM Jun 2026 | $0 | -100.0% | — | 0.0% |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AGX) | $1.81M | +51.5% | +58.2% | 0.1% | |
Competitors are the stored peer set for AGX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 35.71M | 34.7M | 32.36M | 85.46M | 137.77M |
| Depreciation & Amortization | 4.24M | 3.72M | 2.41M | 5.66M | 2.29M |
| Deferred Income Tax | (208K) | (3.23M) | 1.33M | 1.87M | 6.28M |
| Stock-Based Compensation | 3.46M | 3.96M | 4.46M | 4.46M | 7.87M |
| Change in Working Capital | (28.88M) | (69.01M) | 77.97M | 67.88M | 257.39M |
| Accounts Receivables | (480K) | (23.25M) | (20.65M) | (128.61M) | 27.29M |
| Inventory | 5.74M | (9.08M) | 0 | 0 | 0 |
| Accounts Payables | (5.74M) | 9.08M | 0 | 66.23M | 28.64M |
| Other Working Capital | (28.4M) | (45.77M) | 98.62M | 130.27M | 201.47M |
| Other Non-Cash Items | 14.1M | (195K) | (1.67M) | 2.26M | 3.12M |
| Operating Cash Flow | 28.42M | (30.06M) | 116.86M | 167.58M | 414.72M |
| Capital Expenditures | (1.42M) | (3.37M) | (2.76M) | (6.58M) | (3.88M) |
| Acquisitions (Net) | (600K) | 59.75M | (5.11M) | 0 | 0 |
| Purchases of Investments | (95.02M) | (249.75M) | (219.49M) | (314.92M) | (376.65M) |
| Sales of Investments | 90M | 190M | 159.75M | 149.23M | 150M |
| Other Investing Activities | 0 | (59.75M) | 0 | (21.34M) | 48.5M |
| Investing Cash Flow | (7.04M) | (63.12M) | (67.61M) | (193.62M) | (182.02M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 1.43M | 0 | 1.1M | 0 | 0 |
| Common Stock Repurchased | (20.37M) | (68.24M) | (12.46M) | (1.52M) | (9.88M) |
| Dividends Paid | (15.66M) | (13.96M) | (14.68M) | (18.27M) | (24.28M) |
| Other Financing Activities | 1.43M | (611K) | 0 | (6.27M) | (8.44M) |
| Financing Cash Flow | (34.61M) | (82.8M) | (26.05M) | (26.06M) | (42.59M) |
| Effect of Forex Changes | (2.97M) | (539K) | (116K) | 322K | 4.11M |
| Net Change in Cash | (16.2M) | (176.53M) | 23.09M | (51.77M) | 194.22M |
| Free Cash Flow | 26.99M | (33.43M) | 114.1M | 161M | 410.84M |
Argan, Inc.
NYSE:AGX
Intrinsic Alpha fair value
Locked
Current Price
$303.96
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.